Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$38,832,329
+$5,711,430 QoQ
Shares Held
154,317
+1.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#431
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $241,408,936 across 16 Drug Manufacturers - General names. ABBV ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
234,831 | $59,640,029 | |
| 2 | LLY |
ELI LILLY & Co
|
34,121 | $40,925,754 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
154,317 | $38,832,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
190,293 | $24,452,650 | |
| 5 | AMGN |
Amgen Inc
|
43,724 | $15,833,334 | |
| 6 | AZN |
Astrazeneca PLC
|
69,989 | $13,271,314 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
76,216 | $9,629,129 | |
| 8 | NVS |
Novartis AG
|
60,245 | $9,441,596 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,832,329 | 154,317 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $33,120,899 | 152,287 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $38,538,722 | 168,667 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $38,784,802 | 167,508 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $33,109,596 | 178,373 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $39,639,507 | 189,192 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $31,072,088 | 174,857 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $33,694,037 | 170,620 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $28,739,033 | 167,555 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $32,323,478 | 177,504 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $25,553,778 | 164,895 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,586,061 | 158,232 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $19,972,105 | 148,238 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $25,932,845 | 162,721 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $24,401,978 | 150,993 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $19,156,330 | 142,734 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $23,057,472 | 150,545 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $25,713,563 | 158,618 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $18,923,504 | 139,760 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $13,864,207 | 128,527 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $13,352,908 | 118,545 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $10,311,526 | 95,283 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $9,257,009 | 86,393 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,709,831 | 76,605 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $6,888,505 | 70,162 | Shares | Sole | 2020-09-22 | |
| 2020-03-31 | $4,979,702 | 65,359 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||